Seven patients with advanced locoregional or metastatic squamous cell carcinoma of the skin were treated with cis-daimminedichloroplatin (cisplatin) and 5fluorouracil(5-FU). Responses were seen in six of seven patients (three partial responses [PR] and three complete responses [CR]). One patient is
Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma
β Scribed by M. Honda; A. Miura; Y. Izumi; T. Kato; T. Ryotokuji; K. Monma; J. Fujiwara; H. Egashira; T. Nemoto
- Book ID
- 108982320
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 143 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1120-8694
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Six men with either recurrent (n = 4) or unresectable (n = 2) squamous cell carcinoma of the penis (n = 5) and urethra (n = 1) received chemotherapy with cisplatin intravenously at a dose of 100 mg/m2. This was followed 24 hours later by a continuous intravenous infusion of 5-fluorouracil(5-FU) at a
Twenty-nine patients with carcinoma of the esophagus were treated with 5-fluorouracil(5-FU) (1000 mg/ m2/d as a continuous intravenous [IV] infusion on days 1 through 4), cisplatin (100 mg/m2 IV on day I), mitomycin C (10 mg/m2 IV on day I), and concurrent radiation therapy (4500 cCy/4.5 wk). If no